A requirement for copper in angiogenesis.
Although two decades have passed since copper was shown to stimulate blood vessel formation in the avascular cornea of rabbits, only recently have clinical trials established that Cu privation by diet or by Cu chelators diminishes a tumor's ability to mount an angiogenic response. These data have shed new light on the functional role of Cu in microvessel development and, of equal importance, stimulated new nutritional models of cancer therapeutic intervention.
Harris
Edward D
ED
Department of Biochemistry and Biophysics, The Faculty of Nutrition, Texas A&M University, College Station, TX 77843, USA.
D000818:Animals; D017209:Apoptosis / Q000187:drug effects; D002455:Cell Division / Q000187:drug effects; D002614:Chelating Agents / Q000627:therapeutic use*; D003300:Copper / Q000502:physiology*; D003315:Cornea / Q000098:blood supply / Q000187:drug effects; D006133:Growth Substances; D006801:Humans; D008982:Molybdenum / Q000627:therapeutic use; D009369:Neoplasms / Q000098:blood supply* / Q000188:drug therapy / Q000473:pathology; D009389:Neovascularization, Pathologic / Q000517:prevention & control; D009751:Nutritional Requirements
D002614:Chelating Agents; D006133:Growth Substances; D003300:Copper; D008982:Molybdenum; C020809:tetrathiomolybdate